EMA publishes agenda for 25-29 January CHMP meeting

EMA

25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting.

The CHMP is due to issue opinions for the following technologies:

  • Bevacizumab
  • Salmeterol xinafoate with fluticasone propionate
  • Remimazolam
  • Dostarlimab
  • Ofatumumab acetate
  • Selinexor
  • Cenobamate
  • Pemigatinib
  • Somapacitan
  • Thiotepa
  • Icosapent ethyl
  • COVID-19 Vaccine (ChAdOx1-S [recombinant])
  • Comirnaty - COVID-19 mRNA vaccine (nucleoside-modified)
  • COVID-19 Vaccine Moderna – COVID-19 mRNA vaccine (nucleoside-modified)

Read CHMP agenda

Michael Wonder

Posted by:

Michael Wonder